The AltiVate Reverse® Glenoid System offers a modular baseplate with neutral and 15° wedge options, as well as multiple central compression screw lengths and diameters. The baseplate boss was designed to be more bonesparing than any other currently available baseplate with a comparable central through-screw design to minimize the volume of bone removed and preserve the glenoid vault. It also adds four new glenospheres to the already robust RSP® offering, giving surgeons a comprehensive selection to optimize ...

"We are very pleased to offer a modular, augmented baseplate based on the proven central screw fixation principle of our legacy Reverse Shoulder Prosthesis (RSP®) system2," said Louie Vogt, Group President of Enovis™ Reconstructive Business Group. "This addition to our market-leading AltiVate Reverse continues our long history of surgeon-driven innovation and commitment to exceptional patient outcomes." The first surgery using AltiVate Reverse® Glenoid was conducted by Dr. Mark Frankle at Tampa General Hosp ...

Enovis Corp ENOV Loading... On June 13, Repligen named Olivier Loeillot as Chief Executive Officer, effective Sept. 1. The company's stock fell around 28% over the past month and has a 52-week low of $110.45. RSI Value: 22.62 RGEN Price Action: Shares of Repligen fell 2.4% to close at $120.00 on Thursday. Benzinga Pro's real-time newsfeed alerted to latest RGEN's news. Read More: Over $28M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying Loading... The most oversold stocks in the healt ...

The Medical Info Systems industry has witnessed exponential growth thanks to the growing demand for contactless services. The need for a distant treatment option and a paperless environment has led to a tremendous upsurge in digital healthcare options. Added to this is the latest GenAI wave, which has significantly sped up the acceptance and usage of advanced digital healthcare and telemedicine on a global scale. Per GlobalData research, the use of AI in the medical device market is expected to witness a CA ...

A downtrend has been apparent in Enovis (ENOV) lately with too much selling pressure. The stock has declined 15.5% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spottin ...

• aEPS assumes shares of ~56mm aEPS © 2024 Enovis Corporation 7 • Lima integration milestones on track, exciting momentum building globally enovis Three Months Ended enovis. Enovis Corporation Reconciliation of GAAP to Non-GAAP Financial Measures Dollars in millions, except per share data (1) Net loss from continuing operations attributable to Enovis Corporation for the respective periods is calculated using Net loss from continuing operations less the continuing operations component of the income attributa ...

Company Participants Operator Kyle Rose Our earnings release was issued earlier this morning and is available in the Investor Relations section of our website, enovis.com. We will be using a slide presentation in today's call, which can also be found on our website. Both the audio and the slide presentation of this call will be archived on the website later today. Actual results might differ materially from any forward looking statements that we make. The forward looking statements speak only as of today, a ...

Enovis (ENOV) came out with quarterly earnings of $0.50 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this manufacturing and engineering company would post earnings of $0.76 per share when it actually produced earnings of $0.79, delivering a surprise of 3.95%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Enovis, w ...

Enovis Announces First Quarter 2024 Results WILMINGTON, DE, May 2, 2024 (GLOBE NEWSWIRE)—Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended March 29, 2024. The Company will host an investor conference call and live webcast to discuss these results today at 8:00 am ET. First Quarter 2024 Financial Results Enovis' first-quarter net sales of $516 million grew 27% on a reported basis and 5% on a proforma bas ...

Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 2024 at 8:00 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the "Investors" section. Conference call/Webcast Information In ...